Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$6.87 - $11.11 $6,870 - $11,110
-1,000 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$7.7 - $37.13 $8,085 - $38,986
-1,050 Reduced 51.22%
1,000 $9,000
Q3 2021

Nov 09, 2021

SELL
$26.46 - $37.15 $2,646 - $3,715
-100 Reduced 4.65%
2,050 $70,000
Q2 2021

Jul 08, 2021

BUY
$32.73 - $47.95 $16,364 - $23,975
500 Added 30.3%
2,150 $78,000
Q4 2020

May 19, 2021

BUY
$51.77 - $66.18 $20,708 - $26,472
400 Added 32.0%
1,650 $72,000
Q3 2020

Sep 07, 2021

SELL
$43.8 - $58.16 $4,380 - $5,816
-100 Reduced 7.41%
1,250 $62,000
Q2 2020

Sep 07, 2021

BUY
$37.05 - $65.03 $7,409 - $13,006
200 Added 17.39%
1,350 $77,000
Q1 2020

Sep 07, 2021

BUY
$33.63 - $69.4 $6,726 - $13,880
200 Added 21.05%
1,150 $48,000
Q4 2019

Sep 07, 2021

BUY
$31.7 - $69.93 $4,755 - $10,489
150 Added 18.75%
950 $61,000
Q3 2019

Sep 07, 2021

SELL
$19.95 - $38.85 $22,743 - $44,289
-1,140 Reduced 58.76%
800 $26,000
Q2 2019

Sep 07, 2021

BUY
$21.05 - $26.21 $11,577 - $14,415
550 Added 39.57%
1,940 $43,000
Q1 2019

Sep 07, 2021

BUY
$20.65 - $29.55 $5,162 - $7,387
250 Added 21.93%
1,390 $32,000
Q4 2018

Sep 07, 2021

BUY
$19.08 - $36.14 $8,967 - $16,985
470 Added 70.15%
1,140 $23,000
Q3 2018

Sep 07, 2021

BUY
$33.57 - $42.1 $22,491 - $28,207
670 New
670 $25,000
Q1 2018

Sep 07, 2021

SELL
$20.04 - $29.71 $6,012 - $8,913
-300 Closed
0 $0
Q4 2017

Sep 07, 2021

BUY
$16.54 - $24.2 $4,962 - $7,260
300
300 $6,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.